Benoxinate Hydrochloride; Fluorescein Sodium Patent Expiration
Benoxinate Hydrochloride; Fluorescein Sodium is Used for facilitating ocular procedures and examinations in patients requiring a disclosing agent with a topical ophthalmic anesthetic. It was first introduced by Altaire Pharmaceuticals Inc
Benoxinate Hydrochloride; Fluorescein Sodium Patents
Given below is the list of patents protecting Benoxinate Hydrochloride; Fluorescein Sodium, along with the drug name that holds that patent and the company name owning that drug.
Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
---|---|---|---|---|
Fluorescein Sodium And Benoxinate Hydrochloride | US10293047 | Fluorescein and benoxinate compositions | Nov 15, 2037 | Bausch Lomb Ireland |
Fluorescein Sodium And Benoxinate Hydrochloride | US10632197 | Fluorescein and benoxinate compositions | Nov 15, 2037 | Bausch Lomb Ireland |
Fluorescein Sodium And Benoxinate Hydrochloride | US10842872 | Fluorescein and benoxinate compositions | Nov 15, 2037 | Bausch Lomb Ireland |
Coming Soon
Patent Strength Analyzer
![](/_nuxt/img/PatentAnalyzerAd.722976d.jpg)
YesNo
Thank you for your response 🥳